Evidence map›Paper›PMID 41596324›Full record

ArticleInternational journal of molecular sciences2026

Utility of a Digital PCR-Based Gene Expression Panel for Detection of Leukemic Cells in Pediatric Acute Lymphoblastic Leukemia.

Jesús García-Gómez, Dalia Ramírez-Ramírez, Rosana Pelayo, Octavio Martínez-Villegas, Lauro Fabián Amador-Medina, Juan Ramón González-García, Augusto Sarralde-Delgado, Luis Felipe Jave-Suárez, Adriana Aguilar-Lemarroy

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jesús García-GómezPrograma de Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.ORCID 0009-0004-5610-4041
Dalia Ramírez-RamírezLaboratorio de Oncoinmunología y Citómica del Cáncer Infantil, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0002-2740-0317
Rosana PelayoLaboratorio de Oncoinmunología y Citómica del Cáncer Infantil, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla 74360, Mexico.ORCID 0000-0003-3401-9757
Octavio Martínez-VillegasUnidad Médica de Alta Especialidad, Hospital de Gineco-Pediatría No. 48, Centro Médico Nacional del Bajío, León 37328, Mexico.ORCID 0000-0001-8881-1104
Lauro Fabián Amador-MedinaUnidad Médica de Alta Especialidad, Hospital de Especialidades No. 1, Centro Médico Nacional del Bajío, León 37320, Mexico.ORCID 0000-0003-4900-4726
Juan Ramón González-GarcíaDivisión de Genética, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico.ORCID 0000-0003-0284-5114
Augusto Sarralde-DelgadoCoordinación Auxiliar Médica de Investigación en Salud, OOAD Jalisco, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico.ORCID 0000-0001-5628-2041
Luis Felipe Jave-SuárezPrograma de Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0001-6209-5031
Adriana Aguilar-LemarroyPrograma de Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0001-9288-4824

Funding

Mexican Social Security Institute R-2023-785-038Secretaría de Ciencia, Humanidades, Tecnología e Innovación FORDEC-YT-PRONACES 302994
6 · The paper itself

Abstract

Acute lymphoblastic leukemia (ALL) is a genetically heterogeneous disease where current clinical practice guidelines remain focused on traditional cytogenetic markers. Despite recent advances demonstrating excellent diagnostic accuracy for gene expression signatures, a discontinuity exists between biomarker validation and clinical implementation. This study aimed to develop and validate a multiparametric gene expression signature using digital PCR (dPCR) to accurately diagnose pediatric ALL, with potential utility for monitoring measurable residual disease (MRD). We analyzed 130 bone marrow aspirates from pediatric patients from four clinical groups: non-leukemia, MRD-negative, MRD-positive and leukemia characterized by immunophenotype. Gene expression of an 8-gene panel (

Indexed as

Biomarkers, TumorGene Expression ProfilingGene Expression Regulation, LeukemicPolymerase Chain ReactionPrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentChildChild, PreschoolFemaleHumansInfantMaleNeoplasm, ResidualBiomarkers, TumorALLCNPGATA3ICOSLGJUPleukemiaMYCNT5C3BPTK7SNAI1

Identifiers

PMID41596324
PMCPMC12840621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.